NewGenIvf Group Ltd
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in NIVF.
▼ -100.0% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $74.52 | $10,935.00 | $294,300.00 | $275,400.00 | |
| P/E | 33.6x | 0.7x | — | 126.6x | 33.6x |
| P/S | 1.9x | 1.3x | 0.3x | 7.2x | 2.6x |
| P/B | 9.9x | 0.2x | — | 9.9x | 27.4x |
| EPS | $109.44 |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| BDRXBiodexa Pharmaceuticals Plc | $0.87 | — | 0.0x | — | -64.72% | $893.33K |
| BJDXBluejay Diagnostics, Inc. | $0.90 | — | 0.2x | — | -98.89% | $931.24K |
| VTAKCatheter Precision, Inc. | $0.20 | — | 0.0x | — | -111.35% | $724.42K |
| PFSAProfusa, Inc. | $1.69 |
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.
Company description provided by Yahoo Finance.
| -$4,163.83 |
| $2,324.88 |
| $8,190.48 |
| Profit margin | 5.13% | 209.02% | -9.66% | 2.53% | 7.72% |
| ROE | 37.10% | 37.10% | — | 3.49% | 81.45% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| — |
| — |
| — |
| $1.02M |
| CDTCDT Equity Inc. | $1.69 | — | 0.0x | — | -69.68% | $1.33M |
| SXTCChina SXT Pharmaceuticals, Inc. | $3.00 | — | 0.1x | — | -27.49% | $1.6M |